Rituximab in Ocular Adnexal Lymphoma and Orbital Inflammatory Disease

Int Ophthalmol Clin. 2020 Spring;60(2):63-75. doi: 10.1097/IIO.0000000000000301.
No abstract available

MeSH terms

  • Conjunctival Neoplasms*
  • Eye Neoplasms* / drug therapy
  • Humans
  • Immunologic Factors* / therapeutic use
  • Lymphoma* / drug therapy
  • Orbital Diseases* / drug therapy
  • Orbital Neoplasms* / drug therapy
  • Rituximab* / therapeutic use

Substances

  • Immunologic Factors
  • Rituximab